- Q1 2024 ACADIA Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$17.13 (-0.70%)Earnings
- Q4 2023 ACADIA Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024$26.36 (+1.78%)Earnings
- ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- ACADIA Pharmaceuticals Inc at Guggenheim Securities Inflammation & Immunology Conference TranscriptNov 07, 2023
- Q3 2023 ACADIA Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023$22.99 (+0.31%)Earnings
- ACADIA Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- ACADIA Pharmaceuticals Inc at TD Cowen Novel Mechanisms in Neuropsychiatry Summit TranscriptSep 20, 2023
- ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 ACADIA Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2023$29.2 (+0.90%)Earnings
- ACADIA Pharmaceuticals Inc Discuss The Exclusive Worldwide Licensing Of Trofinetide Call TranscriptJul 13, 2023
- ACADIA Pharmaceuticals Inc to Announce Phase 3 Development Candidate ACP-101 Call TranscriptJun 13, 2023
- ACADIA Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 ACADIA Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2023$21.55 (-1.73%)Earnings
- ACADIA Pharmaceuticals Inc Approval Call TranscriptMar 13, 2023
- Q4 2022 ACADIA Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2023$19.4 (+2.54%)Earnings
- ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 ACADIA Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2022$15.93 (+0.44%)Earnings
- ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- ACADIA Pharmaceuticals Inc at Citi BioPharma Conference TranscriptSep 08, 2022
- Q2 2022 ACADIA Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022$16.62 (+1.09%)Earnings
- ACADIA Pharmaceuticals Inc Announces Outcome of FDA Advisory Committee for NUPLAZID® TranscriptJun 17, 2022
- ACADIA Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 ACADIA Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022$19.89 (+0.40%)Earnings
- ACADIA Pharmaceuticals Inc at Needham Neuroscience Forum (Virtual) TranscriptMar 16, 2022
- ACADIA Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Q4 2021 ACADIA Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2022$25.41 (-0.90%)Earnings
- ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2022
- ACADIA Pharmaceuticals Inc Resubmission of sNDA for Pimavanserin for the Treatment of ADP Call TranscriptDec 20, 2021
- ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call TranscriptDec 06, 2021
- Q3 2021 ACADIA Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2021$19.57 (-2.25%)Earnings
- ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- ACADIA Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 ACADIA Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021$21.05 (-2.68%)Earnings
- ACADIA Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- ACADIA Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- ACADIA Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- ACADIA Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 ACADIA Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$19.4 (-0.61%)Earnings
- ACADIA Pharmaceuticals Inc To Discuss Complete Response Letter from U.S. FDA for Supplemental New Drug Application TranscriptApr 05, 2021
- ACADIA Pharmaceuticals Inc Corporate Call - Regulatory Update on Supplemental New Drug Application TranscriptMar 08, 2021
- ACADIA Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- ACADIA Pharmaceuticals Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 26, 2021
- Q4 2020 ACADIA Pharmaceuticals Inc Earnings Call TranscriptFeb 24, 2021$48.69 (-2.11%)Earnings
- ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- ACADIA Pharmaceuticals Inc at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 ACADIA Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2020$49.13 (+5.43%)Earnings
- ACADIA Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- ACADIA Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) - Panel: Emerging Therapies for Psychiatric Disorders TranscriptSep 09, 2020
- ACADIA Pharmaceuticals Inc at JMP Securities CNS Forum (Virtual) TranscriptAug 19, 2020
- Q2 2020 ACADIA Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020$42.87 (-1.49%)Earnings
- ACADIA Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 23, 2020
- ACADIA Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- ACADIA Pharmaceuticals Inc at RBC Global Healthcare Conference TranscriptMay 19, 2020
- ACADIA Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 ACADIA Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$49.34 (+2.41%)Earnings
- Q4 2019 ACADIA Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2020$40.22 (-1.11%)Earnings
- ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- ACADIA Pharmaceuticals Inc to Host Investor Event and Webcast From Clinical Trials on Alzheimer's Disease (CTAD) Meeting TranscriptDec 05, 2019
- ACADIA Pharmaceuticals Inc Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin - Corporate Call TranscriptNov 25, 2019
- Q3 2019 ACADIA Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2019$43.05 (+1.87%)Earnings
- ACADIA Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- ACADIA Pharmaceuticals Inc ACADIA Pharmaceuticals Announces Pivotal Phase 3 HARMONY Trial TranscriptSep 09, 2019
- Q2 2019 ACADIA Pharmaceuticals Inc Earnings Call TranscriptJul 31, 2019$24.58 (-1.68%)Earnings
- ACADIA Pharmaceuticals Inc Corporate Call Announces Top-line Results from Phase 3 ENHANCE Trial TranscriptJul 22, 2019
- ACADIA Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- ACADIA Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 ACADIA Pharmaceuticals Inc Earnings Call TranscriptMay 01, 2019$23.66 (-1.62%)Earnings
- Q4 2018 ACADIA Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2019$23.56 (-0.80%)Earnings
Q1 2024 ACADIA Pharmaceuticals Inc Earnings Call Transcript
Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 Financial Results and Operating Overview Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.
I would now like to hand the conference over to Al Kildani, Senior Vice President of Investor Relations and Corporate Communications. Please proceed.
Thank you. Good afternoon, and thank you for joining us on today's call to discuss ACADIA's First Quarter 2024 Earnings.
Joining me on the call today from ACADIA are Steve Davis, our Chief Executive Officer, who will provide some opening remarks followed by Brendan Teehan, our Chief Operating Officer and Head of Commercial, who will discuss our strong commercial franchises, debut and NUPLAZID. Also joining us is Kimberly Manhard, Senior Vice President of Global Strategic Planning and Execution, who will provide an update on our pipeline programs. And Mark
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)